FDA.reportPublic FDA data

Xeglyze 0.74 % Topical Lotion

RxCUI
2475541
RxNorm name
Xeglyze 0.74 % Topical Lotion
Display name
Xeglyze 0.74 % Topical Lotion
Full name
Xeglyze 0.74 % Topical Lotion
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4fe38e95-8738-a28f-4079-43eff7318cb9Xeglyze 0.74 % Topical Lotion [PSN] · abametapir 7.4 MG/ML Topical Lotion [Xeglyze] [SBD] · Xeglyze 0.74 % Topical Lotion [SY] · Xeglyze 7.4 MG/ML Topical Lotion [SY]44These highlights do not include all the information needed to use XEGLYZE TM safely and effectively. See full prescribing information for XEGLYZE. XEGLYZE (abametapir) lotion, for topical use Initial U.S. Approval: 202020240730